441765-93-1Relevant academic research and scientific papers
Dipeptides as effective prodrugs of the unnatural amino acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740), a selective group II metabotropic glutamate receptor agonist
Bueno, Ana Belén,Collado, Iván,De Dios, Alfonso,Domínguez, Carmen,Martín, José Alfredo,Martín, Luisa M.,Martínez-Grau, María Angeles,Montero, Carlos,Pedregal, Concepción,Catlow, John,Coffey, D. Scott,Clay, Michael P.,Dantzig, Anne H.,Lindstrom, Terry,Monn, James A.,Jiang, Haiyan,Schoepp, Darryle D.,Stratford, Robert E.,Tabas, Linda B.,Tizzano, Joseph P.,Wright, Rebecca A.,Herin, Marc F.
, p. 5305 - 5320 (2007/10/03)
(+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (1), also known as LY354740, is a highly potent and selective agonist for group II metabotropic glutamate receptors (mGlu receptors 2 and 3) tested in clinical trials. It has been shown to block anxiety in the fear-potentiated startle model. Its relatively low bioavailability in different animal species drove the need for an effective prodrug form that would produce a therapeutic response at lower doses for the treatment of anxiety disorders. We have investigated the increase of intestinal absorption of this compound by targeting the human peptide transporter hPepT1 for active transport of di- and tripeptides derived from 1. We have found that oral administration of an N dipeptide derivative of 1 (12a) in rats shows up to an 8-fold increase in drug absorption and a 300-fold increase in potency in the fear-potentiated startle model in rats when compared with the parent drug 1.
An efficient synthesis of LY544344?HCl: A prodrug of mGluR2 agonist LY354740
Coffey, D. Scott,Hawk, Mai Khanh,Pedersen, Steven W.,Vaid, Radhe K.
, p. 7299 - 7302 (2007/10/03)
LY544344?HCl was efficiently prepared in two steps from LY354740. The key step highlighted the in situ masking of the carboxylic acid groups as trimethylsilyl esters to facilitate an effective acylation reaction.
